ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

January 2022, Vol 79, No. 1, Pages 3-87

Viewpoint

Expanding Current Approaches to Solve the Opioid Crisis

Abstract Full Text
JAMA Psychiatry. 2022;79(1):5-6. doi:10.1001/jamapsychiatry.2021.3136

This Viewpoint describes the opioid use disorder cascade of care model, which emcompasses prevention, identification, treatment, and recovery.

Right-Based Mental Health Care—Advantages of Tax-Financed Universal Mental Health Care: Lessons From Denmark

Abstract Full Text
JAMA Psychiatry. 2022;79(1):7-8. doi:10.1001/jamapsychiatry.2021.3167

This Viewpoint illustrates tax-financed, universally available mental health care with experiences from Denmark.

Editorial

Testing for Antisuicidal Effects of Lithium Treatment

Abstract Full Text
JAMA Psychiatry. 2022;79(1):9-10. doi:10.1001/jamapsychiatry.2021.2992

Increasing the Impact of Prevention of Depression—New Opportunities

Abstract Full Text
JAMA Psychiatry. 2022;79(1):11-12. doi:10.1001/jamapsychiatry.2021.3153
Original Investigation

Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial

Abstract Full Text
open access has active quiz
JAMA Psychiatry. 2022;79(1):13-23. doi:10.1001/jamapsychiatry.2021.2669

This randomized clinical trial tests whether pain reprocessing therapy can provide durable and substantial relief from chronic back pain and investigates treatment mechanisms.

Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial

Abstract Full Text
free access has audio
JAMA Psychiatry. 2022;79(1):24-32. doi:10.1001/jamapsychiatry.2021.3170

This randomized clinical trial assesses whether the addition of lithium to existing medication regimens would prevent or delay repeated suicide-related events and whether it could be used safely.

Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia: A Randomized Clinical Trial

Abstract Full Text
open access
JAMA Psychiatry. 2022;79(1):33-41. doi:10.1001/jamapsychiatry.2021.3422

This randomized clinical trial of adults without depression but with insomnia assesses whether insomnia treatment can prevent depression.

Association of Single-blind Placebo Run-in Periods With the Placebo Response in Randomized Clinical Trials of Antidepressants: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):42-49. doi:10.1001/jamapsychiatry.2021.3204

This meta-analysis of 347 trials examines the association of the use of placebo run-in periods with the placebo response, drug response, and drug-placebo difference among randomized clinical trials of antidepressants.

Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):50-58. doi:10.1001/jamapsychiatry.2021.3193

This cross-sectional study examines the prevalence of co-occurring psychiatric and medical conditions in prenatal hospitalizations of individuals with and without cannabis use disorder by concomitant substance use disorders.

Comparing Copy Number Variations in a Danish Case Cohort of Individuals With Psychiatric Disorders

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):59-69. doi:10.1001/jamapsychiatry.2021.3392

This cohort study examines the prevalence and penetrance of copy number variants across the major recurrent copy number variants that are associated with risk for psychiatric disorders.

Special Communication

Addressing Structural Racism in Psychiatry With Steps to Improve Psychophysiologic Research

Abstract Full Text
JAMA Psychiatry. 2022;79(1):70-74. doi:10.1001/jamapsychiatry.2021.2663

This Special Communication discusses how undersampling of racial and ethnic minority individuals has led to overgeneralized physiological findings, the implications for development of psychiatric treatments, and steps to improve service to racially diverse communities.

Neuroscience and Psychiatry

Computational Psychiatry Across Species to Study the Biology of Hallucinations

Abstract Full Text
JAMA Psychiatry. 2022;79(1):75-76. doi:10.1001/jamapsychiatry.2021.3200

This article explains methods for computational psychiatry to study hallucinations in humans and murine models.

Research Letter

Long-term Arrhythmia Detection Using an Implantable Loop Recorder in Patients Receiving Psychotropic Medication

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):77-78. doi:10.1001/jamapsychiatry.2021.2809

This cohort study evaluates the incidence of arrhythmia in patients receiving psychotropic medication by monitoring of electrocardiographic findings using an implantable loop recorder.

Deletion of Loss-of-Function–Intolerant Genes and Risk of 5 Psychiatric Disorders

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):78-81. doi:10.1001/jamapsychiatry.2021.3211

This study examines 2 gene-level metrics of variation constraint against protein-truncating variants—probability of loss-of-function intolerance and loss-of-function observed/expected upper bound fraction—and their association with the psychiatric consequences of both recurrent and nonrecurrent gene deletions.

Insights Into Mixing Fentanyl and Benzodiazepines From Canadian Drug Seizures

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):81-83. doi:10.1001/jamapsychiatry.2021.3292

This cohort study uses data from the Drug Analysis Service of Health Canada to describe changes in the presence of benzodiazepines mixed with fentanyl in drug seizures in Canada from 2018 to 2021.

Comment & Response

Limitations in Research on Maintenance Treatment for Individuals With Schizophrenia

Abstract Full Text
JAMA Psychiatry. 2022;79(1):83-85. doi:10.1001/jamapsychiatry.2021.3400

Limitations in Research on Maintenance Treatment for Individuals With Schizophrenia

Abstract Full Text
JAMA Psychiatry. 2022;79(1):85-86. doi:10.1001/jamapsychiatry.2021.3452

Limitations in Research on Maintenance Treatment for Individuals With Schizophrenia—Reply

Abstract Full Text
JAMA Psychiatry. 2022;79(1):86-87. doi:10.1001/jamapsychiatry.2021.3403
Correction

Add Open Access

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):87. doi:10.1001/jamapsychiatry.2021.3277

Error in Table 1

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):87. doi:10.1001/jamapsychiatry.2021.3312

Numeric Error in Figure 1

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):87. doi:10.1001/jamapsychiatry.2021.4029
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2022;79(1):3. doi:10.1001/jamapsychiatry.2021.3023
×